Brian P. McKeon - 12 Nov 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Issuer symbol
IDXX
Transactions as of
12 Nov 2021
Net transactions value
-$5,100,272
Form type
4
Filing time
15 Nov 2021, 16:00:31 UTC
Previous filing
12 Nov 2021
Next filing
11 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $625,916 +9,225 +35% $67.85 35,542 12 Nov 2021 Direct
transaction IDXX Common Stock Sale $4,314,062 -6,952 -20% $620.55 28,590 12 Nov 2021 Direct F1
transaction IDXX Common Stock Sale $1,412,126 -2,273 -8% $621.26 26,317 12 Nov 2021 Direct F2
holding IDXX Common Stock 18,050 12 Nov 2021 by Estony McKeon Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -9,225 -100% 0 12 Nov 2021 Common Stock 9,225 $67.85 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $620.00 to $621.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $621.045 to $621.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.
F4 Not applicable.